CVS Caremark (CVS) to Acquire Apria's Coram in $2.1B Deal
Tweet Send to a Friend
CVS Caremark (NYSE: CVS) has entered into an agreement to acquire Coram LLC ("Coram"), the specialty infusion services and enteral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE